Cerity Partners
TLSI icon

Cerity Partners’s TriSalus Life Sciences TLSI Stock Holding History

Cerity Partners’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.15M Buy
+787,272
New +$3.85M ﹤0.01% 1235

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Cerity Partners's TLSI Position: Q1 2026 in Review

Cerity Partners opened a new position in TriSalus Life Sciences (TLSI) in Q1 2026: 787,272 shares worth $3.15M. The stake represents ﹤0.01% of the portfolio and ranks #1235 among its holdings.

84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Cerity Partners held 787,272 shares of TriSalus Life Sciences worth $3.15M as of Q1 2026.
  • TriSalus Life Sciences was a new Cerity Partners position in Q1 2026.
  • TriSalus Life Sciences made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1235 holding.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.